J3247 Injection secukinumab intrav 1mg
Also known as: secukinumab, Cosentyx, interleukin-17 inhibitor
Secukinumab intravenous 1 milligram injection is a monoclonal antibody targeting interleukin-17 used for moderate to severe psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Clinical Context
Indicated for moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Blocks interleukin-17 signaling. Intravenous formulation for intensive treatment initiation.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.